{
    "clinical_study": {
        "@rank": "87162", 
        "arm_group": {
            "arm_group_label": "Structural or Valvular Heart Disease"
        }, 
        "brief_summary": {
            "textblock": "This study will compare 3 dimensional intracardiac echo (ICE) with 2 dimensional ICE or\n      transesophageal echo in patients with structural and valvular heart disease who are already\n      scheduled to undergo a percutaneous intervention. Specifically those patients would be those\n      scheduled for a PFO or ASD repair, mitral balloon valvuloplasty, diagnostic cardiac\n      catheterization assessment of aortic stenosis and those undergoing transcatheter aortic\n      valve replacement."
        }, 
        "brief_title": "A PHASE 1 FEASIBILITY STUDY OF VOLUME INTRACARDIAC ECHO IN ASSESSMENT OF PATIENTS WITH STRUCTURAL AND VALVULAR HEART DISEASE UNDERGOING PERCUTANEOUS TRANSCATHETER THERAPY", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Structural and Valvular Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Heart Diseases", 
                "Heart Valve Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients in the study population referred to the cardiac catheterization laboratory\n             for a percutaneous procedure to treat structural or valvular heart disease\n\n        Exclusion Criteria:\n\n          -  Class IV CHF, inadequate femoral access, coagulation abnormalities, intracariac\n             thrombus or DVT"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with structural or valvular heart disease"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669551", 
            "org_study_id": "UPenn 815656"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 16, 2012", 
        "number_of_groups": "1", 
        "official_title": "A PHASE 1 FEASIBILITY STUDY OF VOLUME INTRACARDIAC ECHO IN ASSESSMENT OF PATIENTS WITH STRUCTURAL AND VALVULAR HEART DISEASE UNDERGOING PERCUTANEOUS TRANSCATHETER THERAPY", 
        "overall_official": {
            "affiliation": "University of Pennsylvania", 
            "last_name": "Howard Herrmann, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669551"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Pennsylvania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}